Two Novel Mouse Models of Duchenne Muscular Dystrophy with Similar Dmd Exon 51 Frameshift Mutations and Varied Phenotype Severity. [PDF]
Int J Mol SciBaikova IP +12 more
europepmc +1 more source
Pharmacological Treatments and Therapeutic Targets in Muscle Dystrophies Generated by Alterations in Dystrophin-Associated Proteins. [PDF]
Medicina (Kaunas)Luna-Angulo A +10 more
europepmc +1 more source
Micro-utrophin Therapy for Duchenne Muscular Dystrophy [PDF]
Molecular Therapy, 2019 openaire +3 more sources
A Mechano-kinetic Model For The Myosin-V Walking Mechanism [PDF]
, 2009 Craig, Erin M., Linke, Heiner
core +1 more source
Dystrophin- and Utrophin-Based Therapeutic Approaches for Treatment of Duchenne Muscular Dystrophy: A Comparative Review. [PDF]
BioDrugsSzwec S +3 more
europepmc +1 more source
Striking Cardioprotective Effects of an Adiponectin Receptor Agonist in an Aged Mouse Model of Duchenne Muscular Dystrophy. [PDF]
Antioxidants (Basel)Abou-Samra M +9 more
europepmc +1 more source
The Role of MicroRNA in the Pathogenesis of Duchenne Muscular Dystrophy. [PDF]
Int J Mol SciKiełbowski K +4 more
europepmc +1 more source
The role of dystrophin isoforms and interactors in the brain. [PDF]
BrainTetorou K +4 more
europepmc +1 more source
Retention of stress susceptibility in the mdx mouse model of Duchenne muscular dystrophy after PGC-1α overexpression or ablation of IDO1 or CD38. [PDF]
Hum Mol GenetJohnson EE +6 more
europepmc +1 more source